kw.\*:("Antagoniste analgésique narcotique")
Results 1 to 25 of 2834
Selection :
The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestineBIANCHI, G; FIOCCHI, R; PERACCHIA, F et al.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 5, pp 326-330, issn 0022-3573Article
Naloxone administration following brief exposure to novelty reduces activity and rearing in mice upon 24-h retest: a conditioned aversion?RODGERS, R. J; RICHARDS, C; PRECIOUS, J. I et al.Psychopharmacologia. 1984, Vol 82, Num 4, pp 322-326, issn 0033-3158Article
Is the direct effect of naloxone on liver cell metabolism an artifact?CALDECOURT, M. A; PALMER, T. N; STEARE, S. E et al.Biochimica et biophysica acta. 1983, Vol 759, Num 3, pp 303-305, issn 0006-3002Article
Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonistsVALENTINO, R. J; KATZ, J. L; MEDZIHRADSKY, F et al.Life sciences (1973). 1983, Vol 32, Num 25, pp 2887-2896, issn 0024-3205Article
Hyperthermia in the rat from handling stress blocked by naltrexone injected into the preoptic-anterior hypothalamusPAE, Y.-S; LAI, H; HORITA, A et al.Pharmacology, biochemistry and behavior. 1985, Vol 22, Num 2, pp 337-339, issn 0091-3057Article
Effects of naltrexone on plasma corticosterone in opiate-naive rats: a central actionEISENBERG, R. M.Life sciences (1973). 1984, Vol 34, Num 12, pp 1185-1191, issn 0024-3205Article
Physiologic and morphologic changes and incidence of neoplasms in mice and rats fed naltrexone HCl for 24 monthsROSENKRANTZ, H.The Journal of clinical psychiatry. 1984, Vol 45, Num 9, pp 11-14, issn 0160-6689, sect. 2Article
Changes in ambient temperature alter the blood pressure response to endotoxin and the effectiveness of naloxoneCHEN, C. H; O'LEARY, E. L; JANSSEN, H. F et al.Circulatory shock. 1985, Vol 16, Num 2, pp 185-193, issn 0092-6213Article
Nontolerance to the opioid antagonism of naltrexoneKLEBER, H. D; KOSTEN, T. R; GASPARI, J et al.Biological psychiatry (1969). 1985, Vol 20, Num 1, pp 66-72, issn 0006-3223Article
Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities: evidence for the existence of different μ receptor subtypes in different tissuesSAYRE, L. M; LARSON, D. L; TAKEMORI, A. E et al.Journal of medicinal chemistry (Print). 1984, Vol 27, Num 10, pp 1325-1335, issn 0022-2623Article
Case report: severe hypertension induced by naloxoneLEVIN, E. R; SHARP, B; DRAYER, J. I. M et al.The American journal of the medical sciences. 1985, Vol 290, Num 2, pp 70-72, issn 0002-9629Article
Naltrexone's influence on neurobehavioral developmentZAGON, I. S; MCLAUGHLIN, P. J.Pharmacology, biochemistry and behavior. 1985, Vol 22, Num 3, pp 441-448, issn 0091-3057Article
Antagonism of morphine analgesia by prolyl-leucyl-glycinamide (MIF-1) in humansEHRENSING, R. H; KASTIN, A. J; MICHELL, G. F et al.Pharmacology, biochemistry and behavior. 1984, Vol 21, Num 6, pp 975-978, issn 0091-3057Article
Effects of naloxone, diprenorphine, buprenorphine and etorphine on unpunished and punished food-reinforced responding in the squirrel monkeyDEROSSETT, S. E; HOLTZMAN, S. G.The Journal of pharmacology and experimental therapeutics. 1984, Vol 228, Num 3, pp 669-675, issn 0022-3565Article
ICI 174864: a highly selective antagonist for the opioid δ-receptorCOTTON, R; GILES, M. G; MILLER, L et al.European journal of pharmacology. 1984, Vol 97, Num 3-4, pp 331-332, issn 0014-2999Article
The influence of naloxone on the circulatory effects of captoprilRUBIN, P. C; MILLAR, J. A; STURANI, S et al.British journal of clinical pharmacology. 1984, Vol 17, Num 6, pp 713-717, issn 0306-5251Article
Pulmonary edema following naloxone administration in a patient without heart diseaseTAFF, R. H.Anesthesiology (Philadelphia). 1983, Vol 59, Num 6, pp 576-577, issn 0003-3022Article
Identification of multiple opiate receptors through neuroendocrine responses. II: Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3PECHNICK, R; GEORGE, R; POLAND, R. E et al.The Journal of pharmacology and experimental therapeutics. 1985, Vol 232, Num 1, pp 170-177, issn 0022-3565Article
Modification of kindled amygdaloid seizures by opiate agonists and antagonistsALBERTSON, T. E; JOY, R. M; STARK, L. G et al.The Journal of pharmacology and experimental therapeutics. 1984, Vol 228, Num 3, pp 620-627, issn 0022-3565Article
Naltrexone treatment in a jail work-release programBRAHEN, L. S; HENDERSON, R. K; CAPONE, T et al.The Journal of clinical psychiatry. 1984, Vol 45, Num 9, pp 49-52, issn 0160-6689, sect. 2Article
No effect of naloxone or morphine on plasma catecholamines during hemorrhage in ratFARNEBO, L.-O; ENBERG, U.Acta chirurgica scandinavica. Supplementum. 1984, Num 520, pp 105-108, issn 0301-1860Article
Ocular instillation of naloxone increases intraocular pressure in morphine-addicted patients: a possible test for detecting misuse of morphineDRAGO, F; AGUGLIA, E; DAL BELLO, A et al.Experientia. 1985, Vol 41, Num 2, pp 266-267, issn 0014-4754Article
Hemodynamic effects of hemorrhage and subsequent naloxone treatment in conscious rabbitsSCHADT, J. C; MCKOWN, M. D; MCKOWN, D. P et al.American journal of physiology. Regulatory, integrative and comparative physiology. 1984, Vol 16, Num 3, pp R497-R505, issn 0363-6119Article
Naltrexone induction: psychologic and pharmacologic strategiesKEBER, H. D; KOSTEN, T. R.The Journal of clinical psychiatry. 1984, Vol 45, Num 9, pp 29-38, issn 0160-6689, sect. 2Article
Naltrexone: a clinical perspectiveGREENSTEIN, R. A; ARNDT, I. C; MCLELLAN, A. T et al.The Journal of clinical psychiatry. 1984, Vol 45, Num 9, pp 25-28, issn 0160-6689, sect. 2Article